For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring a…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing. That…
Blog
The unseen costs of banning PBM-owned pharmacies in Tennessee
Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM) and…
Search Posts
Op-Eds
Want to Avoid GM Foods? This Regulation Won’t Help
Yesterday, the European Parliament’s Environment Committee voted to expand the EU’s labelling requirement for Genetically Modified foods. The measure, in the form of…
Op-Eds
Worrying About Frankenstein’s Monster
A specter is haunting Europe—called the “precautionary principle”. As generally defined, the precautionary principle states that a product or technology can be banned even if…
Citation
Cancer Doctors on the FDA
Op-Eds
Battling Hunger With Biotechnology
Needless restrictions on agricultural biotechnology would harm the world's ability to battle hunger in the 21st century, say Gregory Conko and C.S. Prakash, co-founders…
News Release
FDA Too Slow to Approve New Medical Drugs and Devices
A new nationwide poll of cancer specialists sponsored by the Competitive Enterprise Institute finds many of them believe the FDA is too slow in approving…
Study
A National Survey of Oncologists Regarding The Food And Drug Administration
Full Document Available in PDF A National Survey…